Cytochrome P450 2C19 681G > A polymorphism in coronary heart disease patients treated with clopidogrel in Chinese

被引：0
|
作者：
Tang, Xiaofang
Yuan, Jinqing
Yang, Yuejin
机构：
[1] Chinese Acad Med Sci, Key Lab Clin Trial Res Cardiovasc Drugs, Minist Hlth, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100037, Peoples R China
[2] Peking Union Med Coll, Beijing 100037, Peoples R China
来源：
CARDIOLOGY | 2013年 / 126卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：144 / 144
页数：1
相关论文
共 50 条
  • [31] Meta-Analysis of Cytochrome P450 2C19 Polymorphism and Risk of Adverse Clinical Outcomes Among Coronary Artery Disease Patients of Different Ethnic Groups Treated With Clopidogrel
    Jang, Jae-Sik
    Cho, Kyoung-Im
    Jin, Han-Young
    Seo, Jeong-Sook
    Yang, Tae-Hyun
    Kim, Dae-Kyeong
    Kim, Dong-Soo
    Seol, Sang-Hoon
    Kim, Doo-Il
    Kim, Bo-Hyun
    Park, Yong Hyun
    Je, Hyung-Gon
    Jeong, Young-Hoon
    Lee, Seung-Whan
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (04): : 502 - 508
  • [32] Effects of Cytochrome P450 2C19 and Paraoxonase 1 Polymorphisms on Antiplatelet Response to Clopidogrel Therapy in Patients with Coronary Artery Disease
    Tresukosol, Damrus
    Suktitipat, Bhoom
    Hunnangkul, Saowalak
    Kamkaew, Ruttakarn
    Poldee, Saiphon
    Tassaneetrithep, Boonrat
    Likidlilid, Atip
    PLOS ONE, 2014, 9 (10):
  • [33] The effects of cytochrome P450 2C19 polymorphism on the metabolism of voriconazole in vitro
    Xu, Ren-ai
    Gu, Er-min
    Liu, Teng-hui
    Ou-yang, Qiu-geng
    Hu, Guo-xin
    Cai, Jian-ping
    INFECTION AND DRUG RESISTANCE, 2018, 11 : 2129 - 2135
  • [34] Association between cytochrome P450 2C19 polymorphism and clinical outcomes in clopidogrel-treated Uygur population with acute coronary syndrome: a retrospective study
    Yu, Luhai
    Wang, Tingting
    Bai, Huidong
    Zhu, Weijiang
    Li, Yanju
    Wu, Jianhua
    Liu, Wenli
    Sun, Li
    Yu, Aiping
    Li, Hongjian
    BMC CARDIOVASCULAR DISORDERS, 2021, 21 (01)
  • [35] Association between cytochrome P450 2C19 polymorphism and clinical outcomes in clopidogrel-treated Uygur population with acute coronary syndrome: a retrospective study
    Luhai Yu
    Tingting Wang
    Huidong Bai
    Weijiang Zhu
    Yanju Li
    Jianhua Wu
    Wenli Liu
    Li Sun
    Aiping Yu
    Hongjian Li
    BMC Cardiovascular Disorders, 21
  • [36] THE SINGLE NUCLEOTIDE POLYMORPHISMS (SNPs) ASSOCIATED WITH CYTOCHROME P450 2C19 IN PATIENTS ON CLOPIDOGREL THERAPY
    Nazarene, A.
    Chandar, C. S. Ravi
    Kumar, A. M.
    Nagarajan, B.
    Govindarajan, S. R.
    Ranganathan, L. N.
    S, G.
    INTERNATIONAL JOURNAL OF STROKE, 2016, 11 (SUPP 3) : 113 - 113
  • [37] Human Cytochromes P450: Focus on Cytochrome P450 2C19
    Zvyaga, Tatyana
    Chang, Shu-Ying
    Chen, Cliff
    Yang, Zheng
    Vuppugalla, Ragini
    Hurley, Jeremy
    Thorndike, Denise
    Wagner, Andrew
    Chimalakonda, Anjaneya
    Rodrigues, A. David
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (09) : 1698 - 1711
  • [38] Efficacy and Adverse Events of Clopidogrel and Ticagrelor in Patients with Cytochrome P450 2C19 Gene Deletion
    Cai, Xiaofang
    Jiang, S. J.
    Chen, Jiana
    Cai, Xiujuan
    Wang, W. L.
    Huang, J. D.
    Zhang, J. H.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 85 : 175 - 181
  • [39] Cost-effectiveness of cytochrome P450 2C19*2 genotype-guided selection of clopidogrel or ticagrelor in Chinese patients with acute coronary syndrome
    Wang, Y.
    Yan, B. P.
    Liew, D.
    Lee, V. W. Y.
    PHARMACOGENOMICS JOURNAL, 2018, 18 (01): : 113 - 120
  • [40] Cost-effectiveness of cytochrome P450 2C19 *2 genotype-guided selection of clopidogrel or ticagrelor in Chinese patients with acute coronary syndrome
    Y Wang
    B P Yan
    D Liew
    V W Y Lee
    The Pharmacogenomics Journal, 2018, 18 : 113 - 120
12345